PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

Treatment for Subjects With Non-Hodgkin's Lymphoma

NCT00117897 ·Status: COMPLETED ·Phase: PHASE2

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

NCT00490529 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

NCT00529503 ·Status: TERMINATED ·Phase: PHASE2

Reduced Chemotherapy in Low Risk DLBCL

NCT02752815 ·Status: UNKNOWN ·Phase: PHASE4

Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma

NCT00533728 ·Status: COMPLETED ·Phase: PHASE1

A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia

NCT02044276 ·Status: COMPLETED ·Phase: PHASE3

Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma

NCT05221385 ·Status: TERMINATED ·Phase: PHASE1

Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas

NCT00869284 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Diffuse Large B Cell Lymphoma

NCT01949818 ·Status: UNKNOWN ·Phase: PHASE4

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants

NCT05176873 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

NCT01055496 ·Status: COMPLETED ·Phase: PHASE1

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

NCT01856192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

NCT00896519 ·Status: UNKNOWN ·Phase: PHASE2

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

NCT03299738 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

NCT02285062 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

NCT03629873 ·Status: UNKNOWN ·Phase: PHASE2

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

NCT00023166 ·Status: TERMINATED ·Phase: PHASE1

Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

NCT04096690 ·Status: UNKNOWN ·Phase: PHASE2

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

NCT00499018 ·Status: UNKNOWN ·Phase: PHASE3

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

NCT01318317 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

NCT00577629 ·Status: COMPLETED ·Phase: PHASE2

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

NCT00561379 ·Status: COMPLETED ·Phase: NA

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667 ·Status: COMPLETED ·Phase: PHASE2

A Study for Participants With Advanced Cancer

NCT01214629 ·Status: COMPLETED ·Phase: PHASE1

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

NCT00049413 ·Status: COMPLETED ·Phase: PHASE2